Your browser doesn't support javascript.
loading
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.
André, Thierry; Tougeron, David; Piessen, Guillaume; de la Fouchardière, Christelle; Louvet, Christophe; Adenis, Antoine; Jary, Marine; Tournigand, Christophe; Aparicio, Thomas; Desrame, Jérôme; Lièvre, Astrid; Garcia-Larnicol, Marie-Line; Pudlarz, Thomas; Cohen, Romain; Memmi, Salomé; Vernerey, Dewi; Henriques, Julie; Lefevre, Jérémie H; Svrcek, Magali.
Afiliación
  • André T; Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, INSERM 938, SIRIC CURAMUS, Paris, France.
  • Tougeron D; Department of Hepatology and Gastroenterology, Poitiers University Hospital, Poitiers, France.
  • Piessen G; University of Lille, CNRS, INSERM, CHU Lille, Department of Digestive and Oncological Surgery, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
  • de la Fouchardière C; Department of Medical Oncology, Leon Berard Cancer Centre, Lyon, France.
  • Louvet C; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Adenis A; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM, University of Montpellier, Montpellier Cancer Institute (ICM), Montpellier, France.
  • Jary M; University Hospital of Besançon, Clinical Investigational Center, CIC-1431, Besançon, France.
  • Tournigand C; Department of Medical Oncology, Henri Mondor Hospital, AP-HP, Paris-East Créteil University, INSERM, IMRB, Creteil, France.
  • Aparicio T; Paris Cité University, Department of Gastroenterology, Saint Louis Hospital, Paris, France.
  • Desrame J; Cancerology Institute, Jean Mermoz Hospital, Lyon, France.
  • Lièvre A; Department of Gastroenterology, CHU Pontchaillou, INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", Rennes 1 University, Rennes, France.
  • Garcia-Larnicol ML; Oncology Multidisciplinary Group (GERCOR), Paris, France.
  • Pudlarz T; Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, INSERM 938, SIRIC CURAMUS, Paris, France.
  • Cohen R; Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, INSERM 938, SIRIC CURAMUS, Paris, France.
  • Memmi S; Sorbonne University, Department of Pathology, Saint-Antoine Hospital, AP-HP, Paris, France.
  • Vernerey D; Methodology and Quality of Life Unit in Oncology, University of Besançon, Besançon, France.
  • Henriques J; Bourgogne Franche-Comté University, INSERM, Etablissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
  • Lefevre JH; Methodology and Quality of Life Unit in Oncology, University of Besançon, Besançon, France.
  • Svrcek M; Bourgogne Franche-Comté University, INSERM, Etablissement Français du Sang Bourgogne Franche-Comté, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
J Clin Oncol ; 41(2): 255-265, 2023 01 10.
Article en En | MEDLINE | ID: mdl-35969830
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Adenocarcinoma Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article